BDBM176018 US10047103, 51::US9688695, 51

SMILES: COc1nn2cc(nc2s1)-c1cc2c(OCc3csc(n3)N3C[C@H](C)O[C@H](C)C3)cc(OC)cc2o1

InChI Key: InChIKey=XCRBATARHOSVCH-OKILXGFUSA-N

Data: 2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 176018   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Proteinase-activated receptor 4 (PAR4) (Homo sapiens (Human))	BDBM176018 (US10047103, 51 | US9688695, 51) Show SMILES COc1nn2cc(nc2s1)-c1cc2c(OCc3csc(n3)N3C[C@H](C)O[C@H](C)C3)cc(OC)cc2o1 |r| Show InChI InChI=1S/C24H25N5O5S2/c1-13-8-28(9-14(2)33-13)22-25-15(12-35-22)11-32-19-5-16(30-3)6-20-17(19)7-21(34-20)18-10-29-23(26-18)36-24(27-29)31-4/h5-7,10,12-14H,8-9,11H2,1-4H3/t13-,14+	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.260	n/a	n/a	n/a	25
BRISTOL-MYERS SQUIBB COMPANY US Patent					Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ...				US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N
					More data for this Ligand-Target Pair
Proteinase-activated receptor 4 (PAR4) (Homo sapiens (Human))	BDBM176018 (US10047103, 51 | US9688695, 51) Show SMILES COc1nn2cc(nc2s1)-c1cc2c(OCc3csc(n3)N3C[C@H](C)O[C@H](C)C3)cc(OC)cc2o1 |r| Show InChI InChI=1S/C24H25N5O5S2/c1-13-8-28(9-14(2)33-13)22-25-15(12-35-22)11-32-19-5-16(30-3)6-20-17(19)7-21(34-20)18-10-29-23(26-18)36-24(27-29)31-4/h5-7,10,12-14H,8-9,11H2,1-4H3/t13-,14+	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.260	n/a	n/a	n/a	25
Bristol-Myers Squibb Company; Universite de Montreal US Patent					Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L...				US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN
					More data for this Ligand-Target Pair